The Global Photoacoustic (PA) Imaging Market was valued at USD 56.7 Million in 2019 and is forecasted to reach USD 175.8 Million by 2027 at a CAGR of 15.2%.
The global
Photoacoustic Imaging Market will be worth USD 175.8 million by 2027, according
to a current analysis by Emergen Research. It is also known as optoacoustic
imaging which can be defined as a hybrid imaging technique with a high
potential in clinical biomedical application areas as well as multi-scale
preclinical matters. It is one of the rapidly growing biomedical imaging
modalities of the decade, providing sustainable imaging resolution and depth, along
with optical spectroscopic contrast, thereby making it an ideal solution for
real-time functional, structural and molecular imaging of tissue.
Get
your FREE Sample Copy with TOC of the Report to understand the structure of the
complete report@ https://www.emergenresearch.com/request-sample-form/214
Key
participants include illumiSonics Inc., Seno Medical
Instruments Inc InnoLas Laser GmbH, FUJIFILM VisualSonics Inc., kibero, iThera
Medical GmbH, PhotoSound Technologies Inc., PA Imaging, and Teem Photonics
among others.
Biomedical
PA imaging is currently at a rising stage of clinical translation and it is of
utter importance for research institutions as well as academic establishments
to make portable and affordable delivery and detection solutions to expand
smoother transition to clinic. Issue helps to address a wide spectrum of PA
imaging techniques, primarily targeting on latest advances in light sources
along with its delivery methods, w1hich makes detection strategies which help
maintain affordable PA imaging solutions.
Product Outlook (Revenue, USD Billion; 2017-2027)
- Imaging Systems
- Lasers
- Transducers
- Contrast Agents
- Software
End User Outlook (Revenue, USD Billion; 2017-2027)
- Research Institutions
- Hospitals and Clinics
Application Outlook (Revenue, USD Billion; 2017-2027)
- Oncology
- Cardiology
- Neurology
- Hematology
- Others
Key Highlights From The Report.
In June, 2020, Fujifilm VisualSonics Inc., a subsidiary of FUJIFILM SonoSite, Inc. launched the first of its kind ultra high to low frequency ultrasound imaging system equipped with a frequency range from 71-1 MHz. With an open and configurable architecture, this product is specifically targeted towards scientific research community.
The highly going incidence of chronic disorders like cardiovascular diseases and cancer is pressing the utilization of non-invasive and real-time diagnostic methods for detection. When it is compared to traditional ultrasound, the technology is emerging as a crucial diagnostic approach for the detecting as well as managing chronic disorders easy. This is mainly because of its efficiency in the functional characterization of living tissues, the growing demand for PA is increasing in clinical as well as preclinical research favorably for the initial detection of cancer as well as the abnormalities in cardiovascular diseases and microcirculation.
Attributing to the recent technological advancements, the established and emerging manufacturers in the market, are also developing and offering innovative photoacoustic imaging solutions. Furthermore, because of the potential usage in humans, research is underway to develop and produce novel clinical photoacoustic imaging solutions.
To
identify the key trends in the industry and read full summary click on the
link: https://www.emergenresearch.com/industry-report/photoacoustic-imaging-market